TELA News and Press, TELA Bio Inc. From 03/21/22

TELA Bio, Inc. (TELA) Q4 2021 Earnings Conference Call March 21, 2022 16:30 ET Company Participants Louisa Smith - Investor Relations Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Drew Staff...

Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q4 2021 Earnings Call Mar 21, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q4 2021 Earnings Call Transcript

TELA Bio press release (NASDAQ:TELA): Q4 GAAP EPS of -$0.59 misses by $0.07. Revenue of $8.37M (+47.6% Y/Y) beats by $0.4M. For further details see: TELA Bio GAAP EPS of -$0.59 misses by $0.07, revenue of $8.37M beats by $0.4M

MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the...

MALVERN, Pa., March 16, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’...

MALVERN, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the...

TELA Bio (NASDAQ:TELA) launched its SiteGuard No Rinse Antimicrobial Solution for use in plastic reconstructive surgery. The company said SiteGuard uses Next Science's proprietary XBIO Technology that supports surgical site and post-operative infection control by addressing the biofilms ...

MALVERN, Pa., March 03, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the pat...

MALVERN, Pa., Feb. 25, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the ...

TELA Bio, Inc. (TELA) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Hannah Jeffrey - The Gilmartin Group Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants An...